Dogwood Therapeutics Inc. held a special meeting of stockholders on November 21, 2025. Stockholders approved the Second Amended and Restated Equity Incentive Plan, which increases the number of shares reserved for issuance. Approval was also granted for the potential issuance of common stock upon conversion of both the Series A and Series A-2 Non-Voting Convertible Preferred Stock. The adjournment of the special meeting to a later date or dates, if necessary or appropriate, was also approved.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dogwood Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-114919), on November 21, 2025, and is solely responsible for the information contained therein.